Allergan Approved for Augmenting the Chin

FDA has approved Allergan Aesthetics’ Juvéderm Voluma XC for the augmentation of the chin region in adults over the age of 21. The approval marks the second indication for the product, which was previously approved in 2013 for cheek augmentation to correct age-related mid-face volume deficit. The approval was based on data from a pivotal study that demonstrated the product to be safe and effective for augmentation of the chin, with the majority of patients reporting high satisfaction throughout the one-year follow-up, the company says. Product labeling says that Juvéderm should not be used in patients who have severe allergies, marked by a history of anaphylaxis or the presence of multiple severe allergies, and should not be used in patients with a history of allergies to Gram-positive bacterial proteins or lidocaine contained in the product.